A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma.

Author: Huh CH, Seo KI, Park JY, Lim JG, Eun HC, Park KC

Author affiliation: Department of Dermatology, Seoul National University College of Medicine, Korea.

Publication date & source: 2003.01, Dermatology., 206(4):316-20.

Publication type: Clinical Trial; Randomized Controlled Trial

BACKGROUND: Vitamin C is known to both inhibit melanin formation and reduce oxidized melanin. However, vitamin C does not easily penetrate the skin. In this study, vitamin C iontophoresis was employed in order to enhance vitamin C penetration. OBJECTIVE: The purpose of this study was to evaluate the efficacy of vitamin C iontophoresis for melasma patients. METHODS: Twenty-nine females with melasma were enrolled. For iontophoresis, a vitamin C solution was applied to one side of the face, while distilled water was applied to the other side as a control. The L (luminance) value was measured by a colorimeter to obtain an objective pigmentation parameter. RESULTS: Twelve weeks after iontophoresis, the colorimeter of the treated site showed a significant decrease in the L value (from 4.60 to 2.78, p = 0.002), compared to that of the control site (from 4.45 to 3.87, p = 0.142). CONCLUSION: Vitamin C iontophoresis may be an effective treatment modality for melasma. Copyright 2003 S. Karger AG, Basel

Indexes of Skin Care Research Abstracts by Subject Category Most Recent

Web SmartSkinCare.com

Home | About Us | Contact Us | Ask a Question | Resources

Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com
Site Disclaimer | Copyright Certification